From £6.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £6.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Latest News

ROO
premium content

Keep avoiding Deliveroo shares

I have pretty much had the same view on Deliveroo (ROO) shares since its comedy IPO in 2021: by all means have a Deliveroo delivery a couple of times a year, but don’t buy the shares! I last said that in August when the shares were just below a one quid price and, despite lower bond yields and better larger cap markets since, the stock is still about the same price today. And you will not be surprised to know that today’s update is still banging on about how the online food delivery company will be profitable…at some point later this decade!

Bearcast
premium content

Tom Winnifrith Bearcast: But the Welsh Girlies are shite and nobody wants to watch them!

I start with the news that the Welsh women and men's soccer teams will now get equal pay. Does nobody understand economics any more? Then it is onto bitcoin and also Argo Blockchain (ARB). Then Advanced Oncotherapy (AVO) which sounds madder by the day. It certainly does not understand economics. Then nanosynth (NNN) and finally Omega Diagnostics (ODX). I wonder how this Saltire flying Scottish dickhead is doing these days? 
TRX

Tissue Regenix – argues distribution agreement ‘delight’. How’s that balance sheet now?

Regenerative medical device group Tissue Regenix (TRX) has announced it is “delighted to be partnering with Kingsung Medical”for the distribution of OrthoPure XT in China. With its shares currently up by more than 7% on the day at 0.69p – with so many in issue, a £48.5 million market cap, what’s the significance?
EYE
premium content

Eagle Eye Solutions – argues “strong trading and confident outlook”, sufficient for the valuation?

Marketing technology group Eagle Eye Solutions (EYE) has issued a trading update including that it “is confident in delivering another year of profitable growth in line with its expectations”. But what does that mean in the context of a currently up to 542.5p share price?
EQT
premium content

EXPOSE: Whilst the structure of Eqtec related parties looks a concern, it is the business itself that would make me avoid it

A ShareProphets reader has asked me to take a look at Eqtec (EQT), which I’m happy to do as I’ve never exactly been a fan of the company, going back to 2019 when I last covered it.
Crime-Scene
premium content

BREAKING: Good news for Julie “Lingerie on Expenses” Meyer, the FCA fails us all again

A source close to the enquiry confirms that the FCA criminal investigation into Julie Meyer has been ended. She is a free woman. Well apart from that outstanding High Court arrest warrant and unpaid tax bills in the UK, Malta and America and an unsatisfied six figure personal guarantee to Barclays Bank.
EXR

Engage XR – “this coming year is set to be a seminal one”… but not for the reasons it suggests?

Describing itself as “a leading metaverse technology company”, Engage XR (EXR) has issued a trading update including emphasising “revenue for the group is expected to be €3.9m, an increase of 63% on 2021… cash collections in December being slightly ahead of schedule and revenue being better than expected in December”. So what of a current 4.525p share price, down from 13p as recently as last month?
BRBY
premium content

Busy day as Burberry, Currys and Ibstock chat with the market

A busy Wednesday for me. Thank goodness I was not invited to the Davos meeting in Switzerland. Firstly, luxury goods company Burberry (BRBY).
AVO

Advanced Oncotherapy – Worth 156p, Hardman? You’re ‘Avin’ A Giraffe

Paid-for investment "research" prostitute Hardman has released an update on AIM-listed Advanced Oncotherapy (AVO). This means that 1) the company is desperate for cash (no surprises there!), 2) a placing is on the way and 3) that Crispin Odey is sweating over his multiple purchases at a premium at 25p per share when the shares were trading below the 25p par price, given that they are now worth just 11.25p per share. I have much time for Odey, but he has surely called this one spectacularly wrong on multiple occasions.
CBX
premium content

Cellular Goods – just 0.81% of the equity dumped and the shares slump 16%: far worse to come

After hours yesterday there came another TR1 from the chancers Jonathan Bixby and Mike Edwards, aka Durban Holdings, the folks who paid just 0.1p per share to obtain a stake of c31% in Cellular Goods (CBX) at the time of its 5p IPO in late 2021. Oh dear. I have told you repeatedly that this would be messy.
Malcolm

Home of the Knight Witch and Ship of Fools Looks Set to Click Up its Share Price even after today's statement

Hello Share Scramblers. As the snow gently floats past my study window, this old punter can’t see the everlasting craze for cosy indoor armchair gaming becoming less popular. It’s mainly the young who play and they still have disposable income, especially the growing army who still live with their parents. A company called Team 17 (TM17) is an imaginative game maker that sits well in my sights and it has, this morning, served up a cracking statement.

TSCO
premium content

Tesco – “really pleased” with Q3 and Christmas trading, but what’s ahead?

Tesco (TSCO) states that it is “really pleased” with its recent trading performance and that it goes into the new calendar year with good momentum. So what of a current share price up to just above 246p?
Bearcast
premium content

Tom Winnifrith Bearcast: Cellular Goods races towards zero, tough luck David Beckham ( statement on RTO & fund raise needed)

I start with a few words on the weather here in North Wales which brings much joy to my kids and then on Warwick School historic abuse matters. Then it is on to Caracal Gold (GCAT), Corero (CNS), Cellular Goods (CBX), Dev Clever (DEV), Skinbiotherapeutics (SBTX) and THG (THG). 
ENET

Ethernity Networks – its prior announcement indeed attempted ramptastic!, another discounted placing

Ethernity Networks (ENET) has issued an announcement including that it “anticipates that revenues for 2022 will be not less than $2.9 million, an increase of 10%... believe that revenues of $9 million for 2023 are achievable”. So what of a current share price fall from 9.5p towards 7p?
Bully
premium content

Twitter troll glorifies violence against Tom Winnifrith

Will the online harm bill do anything to protect journalists facing constant online harassment including a celebration of violence against them? I doubt it. I bring you Tuesday's TW troller of the day.
WINE
premium content

Naked Wines Trading Update – not so pretty and not so transparent

Naked Wines (WINE) today boasts that its EBIT ( fairly made up earnings) for the year to almost the end of March 2023 will be higher than expected. But there is a warning about 2024 and absolutely no guidance about the real elephant in the room, the ghastly balance sheet. That 2024 warning and the lack of transparency about what really matters are what stink.
OCDO
premium content

Ocado continues to offer great food, but as for its shares…

Whilst typically we are users of J Sainsbury (SBRY), now and again we organise a home food delivery from Ocado (OCDO). Whilst a few bags of food and related from the latter is not cheap, the quality is really good and having a delivery (or two) from it rather than a single restaurant meal is an easy call in my opinion. However, as an investor, I have avoided Ocado shares.
CNS
premium content

Corero – Bullshit earnings, cash burning and a profits warning buried in a release: uninvestable scumbags enter a 26th year of failure

How many times has cyber security group Corero Networks (CNS) lead its shares up the hill with ramptastic announcement after ramptastic announcement only to admit that it was running out of money, needed to do yet another bailout placing and seen its shares slide back down the hill again? Corero has been listed since 1997….
Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

Most Read in the Past Seven Days

That Was the Week that Was

 

ANP

Anpario – a recovery Buy?...

Thursday »

Cat_Fixing_Lightbulb

Bearcast issue update: all should be well

 

ORCP

Oracle Power: Cynical Foul

Time left: 09:13:24